Drug Trial Radar · NCT05809934
A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
220
Actual
Start
Mar 15, 2023
Primary completion
Jul 14, 2025
Study completion Sep 29, 2025
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Apr 12, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Study to Evaluate the Efficacy, Safety and Tolerability of AZD2693 given by subcutaneous injection in adult participants with non-cirrhotic non-alcoholic steatohepatitis with fibrosis and who are carriers of the PNPLA3 148M Risk Allele
Conditions
- Nonalcoholic Steatohepatitis
Interventions
AZD2693Drug
AZD2693 solution SC once per month
PlaceboOther
Sodium chloride 0.9% solution SC once per month
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants Achieving NASH Resolution Without Worsening of Fibrosis Based on Histology After 52 Weeks of TreatmentTime frame: From baseline to week 54
Locations
163 sites in 22 countries. Site status is shown where the registry gives one.
Research Site
Chandler, Arizona
Research Site
Peoria, Arizona
Research Site
Surprise, Arizona
Research Site
Tucson, Arizona
Research Site
Tucson, Arizona
Research Site
Gardena, California
Research Site
La Mesa, California
Research Site
Lancaster, California
Research Site
Los Angeles, California
Research Site
Montclair, California
Research Site
Orange, California
Research Site
Rialto, California
Research Site
Santa Ana, California
Research Site
Boca Raton, Florida
Research Site
Hialeah, Florida
Research Site
Jacksonville, Florida
Research Site
Port Orange, Florida
Research Site
Winter Park, Florida
Research Site
Marietta, Georgia
Research Site
Topeka, Kansas
Research Site
Detroit, Michigan
Research Site
Las Vegas, Nevada
Research Site
Westlake, Ohio
Research Site
Chickasha, Oklahoma
Research Site
Hershey, Pennsylvania
Research Site
Summerville, South Carolina
Research Site
Cordova, Tennessee
Research Site
Austin, Texas
Research Site
Brownsville, Texas
Research Site
Denison, Texas
Research Site
DeSoto, Texas
Research Site
Edinburg, Texas
Research Site
San Antonio, Texas
Research Site
Sugar Land, Texas
Research Site
Richmond, Virginia
Research Site
Seattle, Washington
Research Site
CABA, Argentina
Research Site
CABA, Argentina
Research Site
Ciudad de Buenos Aires, Argentina
Research Site
Córdoba, Argentina
Showing 40 of 163 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.